Yan Cao1, Siwei Zou1, Hui Xu1, Mengxia Li1, Zan Tong2, Min Xu3, Xiaojuan Xu1. 1. College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, China. 2. Department of Physiology, Wuhan University School of Basic Medical Sciences, Wuhan, China. 3. Shanghai Key Laboratory of Magnetic Resonance, Department of Physics, East China Normal University, Shanghai, China.
Abstract
SCOPE: β-Glucans have been shown to reduce the risk of obesity and diabetes. However, they often contain diverse polysaccharides and other ingredients, leading to elusive experimental data and mechanisms. In this study, a pure β-glucan was obtained from the crude Baker's yeast polysaccharides for investigating its effect on the metabolic disorders in high-fat diet induced obese (DIO)/type 2 diabetic (T2D) mice and the underlying mechanism. METHODS AND RESULTS: The Fourier transform infrared spectroscopy and nuclear magnetic resonance spectroscopy data indicated that the pure β-glucan (BYGlc) was a linear β-(1→3)-glucan. It was first found that the oral administration of BYGlc into T2D and DIO mice significantly downregulated the blood glucose through suppressing sodium-glucose transporter-1 expression in intestinal mucosa. Meanwhile, BYGlc promoted glycogen synthesis and inhibited fat accumulation in liver, and depressed macrophage infiltration and pro-inflammatory cytokines production measured by histochemistry/immunohistochemistry and ELISA. Additionally, BYGlc remarkably decreased Firmicutes population and increased the proportion of Akkermansia by 16S rDNA analysis. CONCLUSION: BYGlc showed hypoglycemic activity accompanied by promotion of metabolism and inhibition of inflammation in T2D/DIO mice model. The hypoglycemic mechanisms were first declared to be through suppressing sodium-glucose transporter-1 expression and possibly associated with the altered gut microbiota.
SCOPE: β-Glucans have been shown to reduce the risk of obesity and diabetes. However, they often contain diverse polysaccharides and other ingredients, leading to elusive experimental data and mechanisms. In this study, a pure β-glucan was obtained from the crude Baker's yeastpolysaccharides for investigating its effect on the metabolic disorders in high-fat diet induced obese (DIO)/type 2 diabetic (T2D) mice and the underlying mechanism. METHODS AND RESULTS: The Fourier transform infrared spectroscopy and nuclear magnetic resonance spectroscopy data indicated that the pure β-glucan (BYGlc) was a linear β-(1→3)-glucan. It was first found that the oral administration of BYGlc into T2D and DIO mice significantly downregulated the blood glucose through suppressing sodium-glucose transporter-1 expression in intestinal mucosa. Meanwhile, BYGlc promoted glycogen synthesis and inhibited fat accumulation in liver, and depressed macrophage infiltration and pro-inflammatory cytokines production measured by histochemistry/immunohistochemistry and ELISA. Additionally, BYGlc remarkably decreased Firmicutes population and increased the proportion of Akkermansia by 16S rDNA analysis. CONCLUSION: BYGlc showed hypoglycemic activity accompanied by promotion of metabolism and inhibition of inflammation in T2D/DIO mice model. The hypoglycemic mechanisms were first declared to be through suppressing sodium-glucose transporter-1 expression and possibly associated with the altered gut microbiota.
Authors: Marianna V Rodrigues; Fábio S Zanuzzo; João Fernando A Koch; Carlos Alberto F de Oliveira; Petr Sima; Vaclav Vetvicka Journal: Molecules Date: 2020-11-17 Impact factor: 4.411
Authors: Marcelo M Canaan; Juliana C Reis-Canaan; Márcio G Zangerônimo; Eric F Andrade; Thais M S V Gonçalves; Michel C A Pereira; Renato R Lima; Vanessa Pardi; Ramiro M Murata; Luciano J Pereira Journal: Nutrients Date: 2021-11-26 Impact factor: 5.717